Apollomics, Inc. (APLM)
NASDAQ: APLM · Real-Time Price · USD
14.46
-0.29 (-1.97%)
At close: Nov 21, 2025, 4:00 PM EST
14.74
+0.28 (1.94%)
After-hours: Nov 21, 2025, 5:24 PM EST
Apollomics Market Cap
Apollomics has a market cap or net worth of $31.03 million as of November 21, 2025. Its market cap has increased by 98.73% in one year.
Market Cap
31.03M
Enterprise Value
22.22M
1-Year Change
98.73%
Ranking
Category
Stock Price
$14.46
Market Cap Chart
Since November 26, 2021, Apollomics's market cap has decreased from $129.59M to $31.03M, a decrease of -76.05%. That is a compound annual growth rate of -30.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 21, 2025 | 31.03M | 188.66% |
| Dec 31, 2024 | 10.75M | -87.56% |
| Dec 29, 2023 | 86.40M | -37.89% |
| Dec 30, 2022 | 139.11M | 7.02% |
| Dec 30, 2021 | 129.98M | 0.30% |
| Nov 26, 2021 | 129.59M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 934.14B |
| Johnson & Johnson | 489.26B |
| AbbVie | 405.53B |
| UnitedHealth Group | 282.20B |
| AstraZeneca | 277.11B |
| Novartis AG | 239.24B |
| Merck & Co. | 235.72B |
| Abbott Laboratories | 215.57B |